NEW YORK(GenomeWeb News) – Agilent Technologies said after the close of the market on Thursday that revenues for its fiscal fourth quarter were $1.81 billion, up 5 percent from $1.72 billion in Q4 2013 and matching the consensus Wall Street estimate. 

The company had $1.91 billion in orders for the quarter and year ended Oct. 31, up 4 percent from $1.83 billion a year ago.

The results included Keysight Technologies, formerly Agilent's electronic measurement business, which it spun off Nov. 1.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.